Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04592250

Financial Toxicity in Cancer Patients

Financial Toxicity in Diverse Cancer Populations and Care Settings

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
625 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will seek to generate the early data needed to understand the relationship between constructs and measures of patients' coping resources and psychological response and measures of patients' financial toxicity. To collect this early descriptive data, the overall goal of this study is to identify social, behavioral, and knowledge factors associated with financial toxicity outcomes. Identifying these factors will ultimately help elucidate targets for behavioral, psychosocial, and/or educational and coaching interventions.

Detailed description

PRIMARY OBJECTIVES: 1. Examine the associations between measures of self-efficacy, quality of social support, and financial literacy with the outcome measure of financial toxicity. 2. Identify the feasibility of collecting these measures in a Spanish-speaking cancer patient population. 3. Describe the relationship between financial toxicity and clinical outcomes (survival and disease status). This is an exploratory aim. 4. a) Describe the correlation between measures of self-efficacy, quality of social support, financial literacy and clinical and demographic patient characteristics with outcome measure of financial toxicity, by tumor type and age subgroups. b) Describe response rate to the financial toxicity measure (\>50% completed items on the survey instrument), by tumor type and age subgroups. This is an exploratory aim. OUTLINE: Participants will complete a survey packet that is estimated to take about 30 minutes. The survey packet will be collected at baseline and at 6 months.

Conditions

Interventions

TypeNameDescription
OTHERSurvey AdministrationComplete survey

Timeline

Start date
2020-09-12
Primary completion
2028-09-01
Completion
2028-09-01
First posted
2020-10-19
Last updated
2026-04-16

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04592250. Inclusion in this directory is not an endorsement.